Live Breaking News & Updates on Digm Biosciences

Stay updated with breaking news from Digm biosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

IGM Biosciences (NASDAQ:IGMS) Shares Gap Down to $10.07

IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report) shares gapped down prior to trading on Monday . The stock had previously closed at $10.07, but opened at $9.85. IGM Biosciences shares last traded at $9.94, with a volume of 15,541 shares changing hands. Wall Street Analyst Weigh In IGMS has been the subject of a […] ....

Dekabank Deutsche Girozentrale , Fred Schwarzer , Nisa Investment Advisors , Securities Exchange Commission , Royal Bank , Capital Partners , Biosciences Inc , Igm Biosciences Inc , Exchange Traded Concepts , Get Free Report , Stock Down , Advisors Lp Baker , Exchange Commission , Investment Advisors , Traded Concepts , Bank Deutsche Girozentrale , Fire Capital , Death Receptor , Digm Biosciences , Nasdaq Igms ,

Pale Fire Capital SE Acquires New Position in IGM Biosciences, Inc. (NASDAQ:IGMS)

Pale Fire Capital SE bought a new stake in IGM Biosciences, Inc. (NASDAQ:IGMS – Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 12,601 shares of the company’s stock, valued at approximately $105,000. Several other hedge funds and […] ....

Nova Scotia , Stifel Nicolaus , Bruce Keyt , Pricet Rowe Associates Inc , Biosciences Inc , Morgan Stanley , Blackrock Inc , Artal Group , Securities Exchange Commission , Royal Bank , Exchange Commission , Pale Fire Capital , Free Report , Advisors Lp Baker , Visit Holdingschannel , Digm Biosciences , Nasdaq Igms , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

IGM Biosciences (NASDAQ:IGMS) Trading Down 6%

IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report)’s stock price was down 6% during trading on Wednesday . The stock traded as low as $15.06 and last traded at $15.11. Approximately 40,803 shares traded hands during mid-day trading, a decline of 87% from the average daily volume of 310,863 shares. The stock had previously closed […] ....

Stifel Nicolaus , Fred Schwarzer , Raymond James Associates , Jpmorgan Chase Co , Securities Exchange Commission , Swiss National Bank , Igm Biosciences Inc , Us Bancorp , Morgan Stanley , Biosciences Inc , Biosciences Company Profile , Royal Bank , Get Free Report , Stock Down , Exchange Commission , Advisors Lp Baker , National Bank , Rhumbline Advisers , Digm Biosciences , Nasdaq Igms ,

IGM Biosciences (NASDAQ:IGMS) Shares Down 6%

IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report)’s stock price traded down 6% during mid-day trading on Wednesday . The stock traded as low as $15.06 and last traded at $15.11. 40,803 shares traded hands during mid-day trading, a decline of 87% from the average session volume of 310,863 shares. The stock had previously closed […] ....

United States , Stifel Nicolaus , Fred Schwarzer , Securities Exchange Commission , Jpmorgan Chase Co , Raymond James Associates , Us Bancorp , Igm Biosciences Inc , Swiss National Bank , Biosciences Inc , Biosciences Company Profile , Morgan Stanley , Royal Bank , Get Free Report , Advisors Lp Baker , Exchange Commission , National Bank , Rhumbline Advisers , Digm Biosciences , Nasdaq Igms ,

IGM Biosciences (NASDAQ:IGMS) Shares Down 6%

IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report)’s stock price traded down 6% during mid-day trading on Wednesday . The stock traded as low as $15.06 and last traded at $15.11. 40,803 shares traded hands during mid-day trading, a decline of 87% from the average session volume of 310,863 shares. The stock had previously closed […] ....

United States , Fred Schwarzer , Stifel Nicolaus , Swiss National Bank , Igm Biosciences Inc , Us Bancorp , Raymond James Associates , Jpmorgan Chase Co , Securities Exchange Commission , Royal Bank , Morgan Stanley , Biosciences Inc , Biosciences Company Profile , Get Free Report , Advisors Lp Baker , Exchange Commission , National Bank , Rhumbline Advisers , Digm Biosciences , Nasdaq Igms ,